Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Cost of Revenue (2020 - 2025)

Stemtech's Cost of Revenue history spans 6 years, with the latest figure at $8061.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue fell 99.11% year-over-year to $8061.0; the TTM value through Sep 2025 reached -$816698.0, down 154.23%, while the annual FY2024 figure was $109931.0, 89.02% down from the prior year.
  • Cost of Revenue for Q3 2025 was $8061.0 at Stemtech, down from $19089.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $907193.0 in Q3 2024 and bottomed at -$861543.0 in Q4 2024.
  • The 5-year median for Cost of Revenue is $133387.0 (2023), against an average of $194566.8.
  • The largest annual shift saw Cost of Revenue skyrocketed 383.33% in 2022 before it crashed 436.5% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $447420.0 in 2021, then soared by 56.65% to $700885.0 in 2022, then crashed by 63.47% to $256027.0 in 2023, then plummeted by 436.5% to -$861543.0 in 2024, then surged by 100.94% to $8061.0 in 2025.
  • Per Business Quant, the three most recent readings for STEK's Cost of Revenue are $8061.0 (Q3 2025), $19089.0 (Q2 2025), and $17695.0 (Q1 2025).